Asieris Pharmaceuticals Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 127
Employees
  • Stock Symbol
  • 688176
Stock Symbol
  • Share Price
  • $2.42
  • (As of Monday Closing)

Asieris Pharmaceuticals General Information

Description

Jiangsu Yahong Meditech Co Ltd is a pharmaceutical company integrating research and development, production and commercialization in the field of focused treatment, providing the integration of diagnosis and treatment for Chinese and global patients Solutions.

Contact Information

Website
www.asieris.cn
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Primary Office
  • 8F Building 56
  • 1000 Jinhai Rd. Pudong
  • Shanghai
  • China

Asieris Pharmaceuticals Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Asieris Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.42 $2.49 $2.36 - $3.13 $1.38B 570M 5.85M -$0.10

Asieris Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
Revenue 0 0 0 0
EBITDA (39,072) (35,646) (24,759) (8,994)
Net Income (39,748) (35,791) (24,954) (9,060)
Total Assets 116,828 129,135 10,397 9,605
Total Debt 2,112 4 13 11
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Asieris Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Asieris Pharmaceuticals‘s full profile, request access.

Request a free trial

Asieris Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Jiangsu Yahong Meditech Co Ltd is a pharmaceutical company integrating research and development, production and commerci
Drug Discovery
Shanghai, China
127 As of 2021
00000
0.000 0000-00-00
00000000 00000

00000000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
000000000000000
Beijing, China
000 As of 0000
00000
0000 0000-00-00
00000000 00000

0000000

od tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
0000 000000000
Cambridge, MA
000 As of 0000
00000
0.000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Asieris Pharmaceuticals Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CANbridge Pharma Formerly VC-backed Beijing, China 000 00000 00000000 00000
0000000 000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Asieris Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Ke Pan Ph.D Co-Founder, Chairman & Chief Executive Officer
To view Asieris Pharmaceuticals’s complete executive team members history, request access »

Asieris Pharmaceuticals Board Members (1)

Name Representing Role Since
Ke Pan Ph.D Asieris Pharmaceuticals Co-Founder, Chairman & Chief Executive Officer 000 0000
To view Asieris Pharmaceuticals’s complete board members history, request access »

Asieris Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Asieris Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Asieris Pharmaceuticals‘s full profile, request access.

Request a free trial